Shanghai, China

Dakun Qin



 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2019-2021

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Profile of Inventor Dakun Qin: Innovations in Orexin Receptor Antagonists

Introduction: Dakun Qin, an accomplished inventor based in Shanghai, China, has made significant strides in the pharmaceutical field with his innovative contributions. With a total of five patents to his name, Qin is recognized for his expertise in developing orexin receptor antagonist compounds and their applications in treating orexin-related diseases.

Latest Patents: Among Dakun Qin's latest patents is the groundbreaking research on the crystal form of orexin receptor antagonist compound 5-3. This patent discloses not only a preparation method for the compound but also provides information on crystalline forms I-IV of the orexin receptor antagonist. Additionally, the patent encompasses processes for preparing these crystalline forms and outlines methods for using them in the treatment of orexin-related diseases.

Career Highlights: Throughout his career, Dakun Qin has worked with notable companies in the pharmaceutical industry, including Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His work at these institutions has allowed him to collaborate with cutting-edge teams and contribute to essential research in drug development.

Collaborations: Collaboration has played a crucial role in Dakun Qin’s career. He has worked alongside promising professionals like Haiying He and Xiaolin Li, leveraging their shared expertise to drive innovation in the field of pharmaceuticals. These cooperative efforts have further enhanced the efficacy of developed compounds and opened new avenues for research.

Conclusion: As an inventor based in Shanghai, Dakun Qin continues to push the boundaries of pharmaceutical advancements. His work on orexin receptor antagonist compounds not only reflects his dedication to innovation but also showcases his significant impact on the treatment of orexin-related diseases. With five patents under his belt, Dakun Qin is undoubtedly a prominent figure in the innovation landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…